Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1427 of 6351
-
New drug aims to shrink polyps in inherited colon cancer condition
Disease control Recruiting nowThis open-label phase II trial tests how well TPST-1495 works in reducing the number of polyps in the small bowel and colon in patients with familial adenomatous polyposis (FAP). FAP is an inherited condition in which numerous polyps (growths that protrude from mucous membranes) …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Cord blood infusion trial aims to beat long COVID fatigue
Symptom relief Not yet recruitingREGENECYTE (HPC, Cord Blood) for treatment in patients with post-COVID.
Phase 3 • Sponsor: StemCyte, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Marines' sleep program aims to lower suicide risk
Symptom relief Recruiting nowThe goal of this study is to test a sleep health program designed specifically for U.S. Marine Corps personnel. Researchers want to determine if this program helps Marines improve the participants sleep quality and overall mental health. The study will evaluate whether the progra…
Phase 2 • Sponsor: San Diego State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New shot could help lower stubborn high cholesterol
Disease control Not yet recruitingThe purpose of this study is to compare the effectiveness, safety of SYH2053 in participants with primary hypercholesterolemia (non-familial) or mixed dyslipidemia on a background of lipid-lowering therapy. This trial plans to enroll 900 Participants.
Phase 3 • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New antibody EPI-326 enters first human trials for tough cancers
Disease control Recruiting nowA phase 1 study to determine the safety, tolerability, PK, PD, and preliminary anti-tumor activity of ascending doses of EPI-326 administered to patients with locally advanced or metastatic HNSCC and to patients with any documented EGFR-mutant locally advanced or metastatic NSCLC…
Phase 1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New lupus drug E6742 enters Mid-Stage trial
Disease control Recruiting nowThe main purpose of the study is to demonstrate the efficacy based on dose response of E6742 compared with placebo as defined by the proportion of participants achieving a response using the British Isles Lupus Assessment Group (BILAG) based Composite Lupus Assessment (BICLA) wit…
Phase 2 • Sponsor: Eisai Co., Ltd. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Poop pills for newborns: could a fecal transplant prevent obesity?
Prevention Recruiting nowThis single-center randomized controlled trial evaluates whether donor-derived fecal microbiota transplantation (FMT) administered within 6 hours after birth can improve gut microbiota development and reduce the risk of immune-mediated and metabolic diseases in infants born by el…
Sponsor: Oulu University Hospital • Aim: Prevention
Last updated Jul 23, 2026 00:00 UTC
-
Head-to-Head: which obesity drug wins for fat loss and heart health?
Disease control Recruiting nowThis randomized, open label, head to head clinical trial directly compares tirzepatide and semaglutide in adults with obesity and metabolic syndrome (N=120, age 20-65, 1:1 randomization). Participants undergo deep phenotyping at baseline, 6 months, and 12 months, including DXA (r…
Sponsor: Tri-Service General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Diabetes meds boost pregnancy chances in PCOS women
Disease control CompletedThe aim of the study is to assess the efficacy of adjuvant therapy dapagliflozin, metformin as monotherapy and combination of both in comparison to control group in induction of ovulation with letrozole in women PCOS, focusing specifically on rates of ovulation and pregnancy.
Phase 3 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Nurses take on PTSD: a new way to get help faster
Symptom relief Recruiting nowPurpose of the Study Post-traumatic stress disorder (PTSD) is a common and serious condition, but many people cannot get the help they need because there are not enough mental health specialists (like psychologists or psychiatrists) available. This study is testing a new program …
Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Virtual workouts may ease chemo nerve damage
Symptom relief Recruiting nowThe purpose of this study is to determine the effectiveness of the EX-CIPN program in reducing the strength of CIPN symptoms and CIPN-related disability and improving the ability to complete everyday activities. This will be done by determining whether it is better to receive the…
Phase 3 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Engineered immune cells take on liver cancer in early trial
Disease control Not yet recruitingA Study of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients with Unresectable Recurrent/Metastatic Hepatocellular Carcinoma.
Early phase 1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Gentle back zaps may help kids with cerebral palsy move easier
Symptom relief Recruiting nowThe goal of this clinical trial is to help understand spinal cord excitability in children with cerebral palsy compared to neurologically typical children. The main questions it aims to answer are: * What are the mechanisms of spinal circuit hyperexcitability in CP? * Can transc…
Sponsor: Martin Piazza • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New drug zanzalintinib tested for advanced liver cancer
Disease control Recruiting nowThis phase Ib/II trial tests the safety, side effects, and best dose of zanzalintinib and how well it works in treating patients with hepatocellular (liver) cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanc…
Phase 1/2 • Sponsor: Devalingam Mahalingam • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New scan could catch breast cancer spread that standard tests miss
Diagnosis Not yet recruitingInvasive squamous cell carcinoma (ISCC) represents 5 to 15% of breast cancers. Despite the rarity of this pathology, the number of patients with Invasive squamous cell carcinoma treated at HCL is significant. Patients at risk of metastasis are usually referred to the HCL Nuclear…
Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Could a High-Tech suit help MS patients walk better?
Symptom relief Recruiting nowThe EXOPULSE Suit is a medical device composed of 50 electrodes capable of stimulating up to 43 major muscle groups throughout the body. The multisite electrical stimulation relaxes tense and spastic muscles, thereby enhancing mobility and balance. This non-invasive body garment …
Sponsor: Otto Bock France SNC • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Ancient herbal mix may shorten radiation mouth pain in cancer patients
Symptom relief Recruiting nowEvaluate the effectiveness and safety of traditional Chinese medicine compound in improving radiotherapy-induced oral mucositis in patients with head and neck malignant tumors.
Phase 2 • Sponsor: West China Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New gel could boost recovery after sinus surgery
Disease control Not yet recruitingEndoscopic sinus surgery (ESS) is commonly performed in patients with chronic rhinosinusitis (CRS) to improve sinus drainage and allow better delivery of topical therapies after surgery. Despite surgery, postoperative inflammation can persist and negatively affect healing and out…
Phase 3 • Sponsor: Amin Javer • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Sickle cell drug pociredir tested for Long-Term safety in 50 patients
Disease control By invitation onlyThis is an open-label study to evaluate the safety and tolerability of long-term treatment with pociredir without a comparator in participants with SCD who have previously been treated and shown benefit with pociredir in feeder study 6058-SCD-101 (NCT05169580). Participants in th…
Phase 2 • Sponsor: Fulcrum Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New heart ablation study targets health disparities in minorities
Disease control Recruiting nowThis pragmatic, prospective, single-arm, multi-center, observational registry will evaluate the safety and effectiveness of PFA for the treatment of atrial fibrillation in underrepresented minority patients using FDA approved Boston Scientific PFA catheters; all data collected wi…
Sponsor: Vivek Reddy • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC